American society of clinical oncology clinical practice guideline update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer
Harold J Burstein, Jennifer J Griggs, Ann A Prestrud, Sarah Temin, Harold J Burstein, Jennifer J Griggs, Ann A Prestrud, Sarah Temin
Abstract
ASCO's technology assessment of the use of aromatase inhibitors in the adjuvant setting was last updated in 2004. ASCO's Update Committee on Aromatase Inhibitors reconvened in May 2009 to update this guideline.
Source: PubMed